IQVIA (IQV) Q4 Revenue Surpasses Expectations; FY26 Outlook Maintained

IQVIA (IQV) reported Q4 revenue of $2.15 billion, up 12% year-over-year, surpassing analysts' average estimate of $2.10 billion. Operating income reached $325 million, exceeding a $300 million median forecast. The company attributed growth to strong performance in digital health and pharma services. For 2026, IQV guided to revenue between $8.1 billion and $8.3 billion, above the midpoint of the $8.0 billion estimate, reflecting continued demand in health technology and managed care solutions.